Alaunos Therapeutics | ZIOP - Ebitda


Alaunos Therapeutics reported $-21.02M in EBITDA for its fiscal quarter ending in March of 2021.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Baxter International USD -447M 873M Dec/2025
Biogen USD 649.7M 76.5M Mar/2026
Bioline Rx USD -554K 2.93M Sep/2025
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Celltrion KRW 17.79B 356.77B Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Curis USD -12.3M 231K Sep/2023
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 9.34B 440M Mar/2026
Gilead Sciences USD 3.02B 1.01B Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Incyte USD 367.97M 46.53M Mar/2026
Intrexon USD -24.7M 2.92M Jun/2024
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Merck USD 6.3B 2.09B Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Organigram Holdings CAD 5.26M 884K Dec/2025
Pfizer USD 5.99B 5.23B Mar/2026
Pharma Mar EUR 2.71M 42.25M Mar/2026
PTC Therapeutics USD -70.99M 91.62M Dec/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sartorius EUR 267.3M 10.1M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
TG Therapeutics USD 51.69M 19M Dec/2025
Tilray USD 8.36M 1.82M Sep/2025
Zealand Pharma A/S -727.47M 285.54M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026